Found 26 matching trials
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial PHASE3 The overall aim of this research is to improve secondary stroke prevention ...
Show More Location
Multiple Locations
Learn More & Join Trial
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) PHASE3 This is an event driven Phase 3, prospective, randomized, open-label, blind...
Show More Location
Banner University Medical Center
Learn More & Join Trial
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty PHASE2 The objective of this study is to assess the efficacy, safety and dose-resp...
Show More Location
Multiple Locations
Learn More & Join Trial
Cancer Venous Thromboembolism (VTE) PHASE3 The primary objective is to demonstrate the non-inferiority of edoxaban (pr...
Show More Location
Multiple Locations
Learn More & Join Trial
PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers PHASE1 This study aims to evaluate the effects of combination therapy of tegopraza...
Show More Location
Jeonbuk National University Hospital
Learn More & Join Trial
CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 PHASE3 There is emerging evidence that patients with SARS-CoV-2 are affected by in...
Show More Learn More & Join Trial
A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation PHASE1 This Phase 1 study consists of 2 parts. Part 1 will be an open-label, rando...
Show More Learn More & Join Trial
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease PHASE3 A committee will judge the safety and effectiveness of edoxaban and the reg...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes PHASE3 NOAH is an investigator-initiated, prospective, parallel-group, double-blin...
Show More Learn More & Join Trial
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). PHASE3 Evaluation of heparin/edoxaban tosylate (DU176b) versus heparin/warfarin in...
Show More Location
Investigational Site 7103
Learn More & Join Trial